Sign in
4

Changes in Ownership

AGIOS PHARMACEUTICALS, INC. Filed Acc 0001439222-22-000006

Chief Financial Officer gave up 1,349 shares (to pay taxes)

  • Chief Financial Officer acquired 3,667 shares (option exercise)

From the SEC's structured data for this filing

Trades in this filing

Biller Jonathan · Chief Financial Officer

Table I: Non-derivative

2 lines
Date Transaction Shares Price Value Owned after D/I
2022-02-10 Exercise or conversion : show line 1 in the form +3,667 18,467 D
2022-02-10 Shares withheld for taxes : show line 2 in the form −1,349 $31.43 $42,392 17,118 D

Table II: Derivative

1 line
Date Transaction Shares Owned after D/I
2022-02-10 Exercise or conversion : show line 3 in the form Restricted stock units −3,667 7,333 D
Loading xslF345X03/wf-form4_164487285754334.xml…